论文部分内容阅读
[摘要] 目的 探讨跨理论模型干预模式对淋巴瘤患者化疗间歇期血象监测依从性的影响。 方法 遴选2018年3月至2019年3月来本科室已接受过化疗的淋巴瘤患者60例,采用随机数字表法分为对照组和实验组各30例。对照组出院后予常规护理随访,实验组结合跨理论模型干预,即依据患者的不同行为特征进行分期并实施相应的推荐措施。两组患者化疗间歇期均予一周一次电话或微信随访,每例患者共观察5个化疗间歇期,比较该理论对患者血象监测的次数、血象监测主客观因素及住院时间的影响。 结果 干预后实验组化疗间歇期血象监测主客观因素评分高于对照组,差异有统计学意义(P<0.01);干预后血象监测次数多于对照组,差异有统计学意义(P<0.05);总住院时间实验组短于对照组,差异有统计学意义(P<0.01)。 结论 跨理论模型可有效提高淋巴瘤患者化疗间歇期血象监测依从性,降低总住院时间。
[关键词] 跨理论模型;化疗间歇期;淋巴瘤;血象监测依從性
[Abstract] Objective To investigate the effect of transtheoretical model intervention on the compliance of patients with lymphoma receiving hemogram monitoring at the intermission of chemotherapy. Methods A total of 60 patients with lymphoma who had received chemotherapy in our department from March 2018 to March 2019 were selected. They were randomly divided into the control group and the experimental group by random number table method, with 30 cases in each group. The control group was given routine nursing and follow-up after discharge, and the experimental group was given routine nursing and follow-up combined with transtheoretical model intervention. Namely, according to the different behavioral characteristics of patients, staging was carried out and the corresponding recommended measures were implemented. Both groups of patients were followed up by phone or WeChat once a week at the intermission of the chemotherapy. Each patient was observed for a total of five intermissions of chemotherapy. The effects of this theory on frequency of hemogram monitoring for the patients, the subjective and objective factors of hemogram monitoring, and hospitalization time were compared. Results The scores of subjective and objective factors of hemogram monitoring at the intermission of chemotherapy in the experimental group after intervention were higher than those in the control group, and the differences were statistically significant(P
[关键词] 跨理论模型;化疗间歇期;淋巴瘤;血象监测依從性
[Abstract] Objective To investigate the effect of transtheoretical model intervention on the compliance of patients with lymphoma receiving hemogram monitoring at the intermission of chemotherapy. Methods A total of 60 patients with lymphoma who had received chemotherapy in our department from March 2018 to March 2019 were selected. They were randomly divided into the control group and the experimental group by random number table method, with 30 cases in each group. The control group was given routine nursing and follow-up after discharge, and the experimental group was given routine nursing and follow-up combined with transtheoretical model intervention. Namely, according to the different behavioral characteristics of patients, staging was carried out and the corresponding recommended measures were implemented. Both groups of patients were followed up by phone or WeChat once a week at the intermission of the chemotherapy. Each patient was observed for a total of five intermissions of chemotherapy. The effects of this theory on frequency of hemogram monitoring for the patients, the subjective and objective factors of hemogram monitoring, and hospitalization time were compared. Results The scores of subjective and objective factors of hemogram monitoring at the intermission of chemotherapy in the experimental group after intervention were higher than those in the control group, and the differences were statistically significant(P